Our data shows that DUX4 and PAX7 signatures are partially overlapping biomarkers for FSHD, both displaying a sporadic expression pattern in FSHD-affected biopsies and—based on correlation with imaging-based biomarkers—each representing different states of disease activity and/or progression. Here, PAX7 is linked to facioscapulohumeral muscular dystrophy.